A Phase 2 Trial of Radium Ra 223 Dichloride in Combination With Androgen Deprivation Therapy and Stereotactic Body Radiation Therapy for Patients With Oligometastatic Castration Sensitive Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 03 Dec 2018
At a glance
- Drugs Radium 223 chloride (Primary) ; Goserelin; Leuprorelin; Leuprorelin
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 11 Apr 2018 Status changed from not yet recruiting to recruiting.
- 22 Mar 2018 Planned End Date changed from 1 Aug 2019 to 1 Dec 2019.